Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.22 USD | +0.95% |
|
+4.76% | +41.17% |
05-24 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
05-24 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.17% | 2.49B | |
+18.89% | 3,289B | |
+18.17% | 90.43B | |
+16.95% | 85.57B | |
+43.45% | 52.49B | |
-20.04% | 50.25B | |
+35.49% | 46.79B | |
+86.37% | 42.74B | |
-34.37% | 41.67B | |
-1.97% | 27.82B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating